Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Mr. Marc  Bistuer

Deputy Chief Executive Officer and Director of Corporate Quality & Compliance

Mr. Bertrand  Havrileck

Head of Corporate R&D

Ms. Nathalie  Pollet

Head of Global Marketing & Market Development

Ms. Sophie  Favini

Head of Global Business Operations

Ms. Sandrine  Brunel

Head of Corporate Communications

Ms. Francesca  Cortella

Head of Corporate Human Resources

Mr. Sebastien  Huron

Chief Executive Officer & Chairman of the Executive Board

Mr. Habib  Ramdani

Chief Financial Officer, Deputy Chief Executive Officer & Member of Executive Board

Manuela  Rodríguez

Director of Financial Projects

Name	Marktkapitalisierung
Marksans Pharma Limited	0M
Luye Pharma Group Ltd.	0M
PT Kalbe Farma Tbk.	0M
Daiichi Sankyo Company, Limited	0M
Astellas Pharma Inc.	0M
NGL Fine-Chem Limited	0M
Bristol-Myers Squibb Company	0M
Orion Oyj	0M
Chugai Pharmaceutical Co., Ltd.	0M
Novartis AG	0M

Virbac SA

Virbac SA Liste der Konkurrenten

Wichtigste Wettbewerber